Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection.
Saved in:
| Title: | Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection. |
|---|---|
| Authors: | Zeuli JD; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA., Adie SK; School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA., Rizza SA; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA., Temesgen Z; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA. temesgen.zelalem@mayo.edu. |
| Source: | Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2015 Nov; Vol. 51 (11), pp. 629-43. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Clarivate Analytics Country of Publication: Spain NLM ID: 101160518 Publication Model: Print Cited Medium: Print ISSN: 1699-3993 (Print) Linking ISSN: 16993993 NLM ISO Abbreviation: Drugs Today (Barc) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26744738 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zeuli+JD%22">Zeuli JD</searchLink>; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Adie+SK%22">Adie SK</searchLink>; School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Rizza+SA%22">Rizza SA</searchLink>; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Temesgen+Z%22">Temesgen Z</searchLink>; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA. temesgen.zelalem@mayo.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101160518%22">Drugs of today (Barcelona, Spain : 1998)</searchLink> [Drugs Today (Barc)] 2015 Nov; Vol. 51 (11), pp. 629-43. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Clarivate+Analytics%22">Clarivate Analytics </searchLink><i>Country of Publication: </i>Spain <i>NLM ID: </i>101160518 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1699-3993 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216993993%22">16993993 </searchLink><i>NLM ISO Abbreviation: </i>Drugs Today (Barc) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26744738 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1358/dot.2015.51.11.2414528 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 629 Titles: – TitleFull: Asunaprevir plus daclatasvir for the treatment of chronic hepatitis C virus infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zeuli JD – PersonEntity: Name: NameFull: Adie SK – PersonEntity: Name: NameFull: Rizza SA – PersonEntity: Name: NameFull: Temesgen Z IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2015 Nov Type: published Y: 2015 Identifiers: – Type: issn-print Value: 1699-3993 Numbering: – Type: volume Value: 51 – Type: issue Value: 11 Titles: – TitleFull: Drugs of today (Barcelona, Spain : 1998) Type: main |
| ResultId | 1 |
